These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 11170260

  • 1. Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal--regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines.
    Cui W, Yazlovitskaya EM, Mayo MS, Pelling JC, Persons DL.
    Mol Carcinog; 2000 Dec; 29(4):219-28. PubMed ID: 11170260
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.
    Persons DL, Yazlovitskaya EM, Cui W, Pelling JC.
    Clin Cancer Res; 1999 May; 5(5):1007-14. PubMed ID: 10353733
    [Abstract] [Full Text] [Related]

  • 3. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101.
    Yazlovitskaya EM, Pelling JC, Persons DL.
    Mol Carcinog; 1999 May; 25(1):14-20. PubMed ID: 10331740
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line.
    Hayakawa J, Ohmichi M, Kurachi H, Ikegami H, Kimura A, Matsuoka T, Jikihara H, Mercola D, Murata Y.
    J Biol Chem; 1999 Oct 29; 274(44):31648-54. PubMed ID: 10531373
    [Abstract] [Full Text] [Related]

  • 5. Role of ERK1/2 kinase in cisplatin-induced apoptosis in human ovarian carcinoma cells.
    Wei SQ, Sui LH, Zheng JH, Zhang GM, Kao YL.
    Chin Med Sci J; 2004 Jun 29; 19(2):125-9. PubMed ID: 15250250
    [Abstract] [Full Text] [Related]

  • 6. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.
    Tong Z, Singh G, Rainbow AJ.
    Cancer Res; 2002 Oct 01; 62(19):5528-35. PubMed ID: 12359764
    [Abstract] [Full Text] [Related]

  • 7. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin.
    Mabuchi S, Ohmichi M, Kimura A, Ikebuchi Y, Hisamoto K, Arimoto-Ishida E, Nishio Y, Takahashi K, Tasaka K, Murata Y.
    Endocrinology; 2004 Mar 01; 145(3):1302-13. PubMed ID: 14645110
    [Abstract] [Full Text] [Related]

  • 8. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
    Kimura A, Ohmichi M, Kurachi H, Ikegami H, Hayakawa J, Tasaka K, Kanda Y, Nishio Y, Jikihara H, Matsuura N, Murata Y.
    Cancer Res; 1999 Oct 15; 59(20):5133-42. PubMed ID: 10537288
    [Abstract] [Full Text] [Related]

  • 9. alpha-TEA inhibits survival and enhances death pathways in cisplatin sensitive and resistant human ovarian cancer cells.
    Yu W, Shun MC, Anderson K, Chen H, Sanders BG, Kline K.
    Apoptosis; 2006 Oct 15; 11(10):1813-23. PubMed ID: 16850165
    [Abstract] [Full Text] [Related]

  • 10. [Rapid inhibition of extracellular signal-regulated kinase 1/2 in a human ovarian cancer cell line by dexamethasone].
    Xia B, Lu J.
    Ai Zheng; 2002 Aug 15; 21(8):868-71. PubMed ID: 12478895
    [Abstract] [Full Text] [Related]

  • 11. Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
    Mansouri A, Ridgway LD, Korapati AL, Zhang Q, Tian L, Wang Y, Siddik ZH, Mills GB, Claret FX.
    J Biol Chem; 2003 May 23; 278(21):19245-56. PubMed ID: 12637505
    [Abstract] [Full Text] [Related]

  • 12. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y, Chen X, Luo Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun 23; 30(6):592-6. PubMed ID: 24909280
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
    Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y.
    Cancer Res; 2000 Nov 01; 60(21):5988-94. PubMed ID: 11085518
    [Abstract] [Full Text] [Related]

  • 14. Differential regulation of extracellular signal-regulated protein kinase 1 and Jun N-terminal kinase 1 by Ca2+ and protein kinase C in endothelin-stimulated Rat-1 cells.
    Cadwallader K, Beltman J, McCormick F, Cook S.
    Biochem J; 1997 Feb 01; 321 ( Pt 3)(Pt 3):795-804. PubMed ID: 9032468
    [Abstract] [Full Text] [Related]

  • 15. Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.
    Song H, Wei M, Liu W, Shen S, Li J, Wang L.
    Histol Histopathol; 2018 Jan 01; 33(1):73-79. PubMed ID: 28287251
    [Abstract] [Full Text] [Related]

  • 16. Requirement for ERK activation in cisplatin-induced apoptosis.
    Wang X, Martindale JL, Holbrook NJ.
    J Biol Chem; 2000 Dec 15; 275(50):39435-43. PubMed ID: 10993883
    [Abstract] [Full Text] [Related]

  • 17. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV, Sun Y, Westbrook L, Rentz SS, Manuvakhova M, Qu Z, Samuel S, Upshaw R, Cunningham A, Kern FG.
    Cancer Res; 2004 Jul 01; 64(13):4637-47. PubMed ID: 15231676
    [Abstract] [Full Text] [Related]

  • 18. Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: a role of c-Jun NH2-terminal kinase 1.
    Li F, Meng L, Zhou J, Xing H, Wang S, Xu G, Zhu H, Wang B, Chen G, Lu YP, Ma D.
    Biochem Biophys Res Commun; 2005 Oct 07; 335(4):1070-7. PubMed ID: 16105650
    [Abstract] [Full Text] [Related]

  • 19. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells.
    Seidman R, Gitelman I, Sagi O, Horwitz SB, Wolfson M.
    Exp Cell Res; 2001 Aug 01; 268(1):84-92. PubMed ID: 11461121
    [Abstract] [Full Text] [Related]

  • 20. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A, Agarwal R, Agarwal C.
    Oncogene; 2003 Mar 06; 22(9):1302-16. PubMed ID: 12618755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.